Ovation 4-Year Results Pivotal Study to Evaluate the Safety and Effectiveness of the Ovation System
|
|
- Dayna Sabina Burns
- 6 years ago
- Views:
Transcription
1 Ovation 4-Year Results Pivotal Study to Evaluate the Safety and Effectiveness of the Ovation System Vascular Health Partners Glens Falls, New York
2 Disclosure Speaker name: I have the following potential conflicts of interest to report: Other Principal Investigator, US Global Ovation Pivotal Trial
3 Limitations of Conventional EVAR 1 = Unmet Clinical Needs 1 Morrison T, Fillinger M, Meyer C, et al. Gender disparities in endovascular treatment options for infrarenal abdominal aortic aneurysms. erences/ucm pdf. Published June 25, Nearly 35% of men and 60% of women remain ineligible for EVAR Inadequate neck length was a main driver of ineligibility Limitations based on narrow access vessels Treatment options limited to surgical repair, fenestrated / branched endografts, off-label EVAR, or watchful waiting
4 Persistent EVAR Challenges Characteristics of Hostile Access Anatomy Narrow (<6mm) Occluded Tortuous Calcified Aneurysmal Narrow Access Vessels 5.3 mm 3.2 mm Access Vessel Tortuosity 40% Patients < 6mm M2S Database 43,000 CT Scans 55% Female Patients <6mm (CHAP) Collaborative effort 1,063 CT Scans
5 Persistent EVAR Challenges Characteristics of Hostile Neck Anatomy Short Aortic Necks (<15mm) Reverse Tapered Necks Calcium Thrombus Severe Angulation Large Diameter Reverse Tapered Necks At Inferior Renal Artery At IR + 5 At IR + 13 Calcium/Thrombus lined Necks 48% Patients < 15mm Necks* M2S Database 43,000 CT Scans 63% Women < 15mm Necks** (CHAP) Collaborative effort 1,063 CT Scans
6 Ovation Global Pivotal Trial A pivotal clinical evaluation of the safety and effectiveness of the TriVascular Ovation Abdominal Stent Graft System Primary Endpoint: MAE within 30 days of the procedure, as determined by Clinical Events Committee Primary Effectiveness Endpoint: Treatment success defined as: Successful Delivery and Deployment Freedom from Rupture and Conversion to Open Surgical Repair Freedom from Type I and III Endoleaks, Migration, and Enlargement as determined by Core Lab Follow-up: 1 month, 6 month and annual to 5 years 5
7 Ovation Global Pivotal Trial Investigator Valdes, Francisco Investigator Brunkwall, Jan Krankenberg, Hans Mathias, Klaus Nolte, Thomas Scheinert, Dierk Sievert, Horst Torsello, Giovanni Site Catholic University Site Uni. Klinik Ko ln Medizinisches Versorgungszentrum, HH Klinikum Dortmund Herz und Gefa ßzentrum, Bad Bevensen Park Krankenhaus, Leipzig CVC, Frankfurt St. Franziskus-Hospital, Münster 161 patients enrolled in Chile, Germany and USA First Global IDE Trial Broadest Indication Statement Included First-In-Man at all sites Investigator Botti, Charles Cheema, Mohiuddin Clair, Daniel Eidt, John Eskandari, Mark Glickman, Mark Gray, Bruce Haser, Paul Hassoun, Heitham Henretta, John Hodgson, Kim Jain, Ash Jicha, Douglas Jones, Paul Jordan, William Kasirajan, Karthik Krajcer, Zvonimir Laird, John Maini, Brijeshwar Makaroun, Michel Maldonado, Thomas Mehta, Manish Mishkel, Gregory Moore, Wesley Motew, Stephen Murkherjee, Dipankar Rizvi, Adnan Sternberg, Charles Site Riverside Methodist Hospital Hartford Hospital Cleveland Clinic Central Arkansas VA Northwestern Memorial Sentara Medical Group Greenville Hospital UMDNJ Methodist Hospital Mission Hospital Southern Illinois University Washington Hospital Santa Rosa Memorial Mercy Medical Center UAB Emory University St. Luke s Hospital UC Davis Moffitt Heart and Vascular UPMC NYU Hospital Albany Medical Center Prairie Heart UCLA Forsyth Medical Center Inova Fairfax Hospital Minneapolis Heart Institute Ochsner Health System
8 Ovation Global Pivotal Trial Subject Demographics Age (Yrs) Mean ± std 73 ± 8 Gender Male % (n/n) 87.6% (141/161) Subject Medical History ASA Grade - I 5.6% (9/161) - II 28.0% (45/161) - III 59.6% (96/161) - IV 6.8% (11/161) Coronary artery disease 44.7% (72/161) Hypertension 84.5% (136/161) Hyperlipidemia 70.2% (113/161) Peripheral vascular disease 23.6% (38/161) Smoking 70.2% (113/161) COPD 27.3% (44/161)
9 Ovation Global Pivotal Trial Baseline Aortoiliac Characteristics Mean ± SD Min, Max Aortic diameter 13mm below renal artery (mm) ± , 32.3 Juxtarenal angle (degrees) ± , 60.0 Proximal neck length (mm) ± , 50.0 Aortic aneurysm diameter (mm) ± , 90.0 Aortic bifurcation diameter (mm) ± , 53.5 Left iliac diameter (mm) ± , 34.0 Left iliac minimum access diameter (mm) ± , 11.5 Right iliac diameter (mm) ± , 23.4 Right iliac minimum access diameter (mm) ± , % (66/161) of Ovation Trial patients treated had access vessels <6mm, aortic neck length <10mm, or both. Neither Criteria 59% Access Vessel <6mm, 25% Both Criteria 8% Neck Length 8% 1 Data provided by site imaging 2 Data provided by imaging core lab
10 Ovation Global Pivotal Trial 4-year results of the global pivotal clinical study to evaluate the safety and effectiveness of the TriVascular Ovation Abdominal Stent Graft System. Technical Success 1 Safety 2 0 to 30 Days N= to 365 Days N= to 730 Days N= to 1095 Days N= to 1460 Days N=124 Major Adverse Events 2.5% 3.8% Device Related MAE 0% 0% Rupture 0% 0% 0% 0% 0% Conversion to Open Repair 0% 0% 0% 0% 0% All N=161 Defined as successful, delivery and deployment of one aortic body and two iliac limbs 100% Effectiveness 3 30 Day 1 Year 2 Years 3 Years 4 Years Type I and III Endoleaks 0% (0/153) 0% (0/143) 0% (0/120) 0% (0/109) 0% (0/85) Migration Baseline 0% (0/150) 0% (0/133) 0% (0/117) 0% (0/94) Data as of July 31, Technical Success based on investigator reports 2 Major Adverse Events and Device Related Major Adverse Events based on Clinical Events Committee (CEC) adjudicated data. Rupture and Conversion to Open Repair based on investigator reports 3 Endoleaks and Migration rates based on Core Lab Data (M2S)
11 Ovation Global Pivotal Trial 120 Aneurysm Diameter Stable or Decreasing 3 and 4 year Rates TriVascular Ovation (U.S.) Cook Zenith High Risk Cook Zenith Standard Risk Endologix XL Endologix Infrarenal Bifurcated 3-year 4-year Endologix Suprarenal Aortic Ext. Endologix Suprarenal Bifurcated Gore Excluder Medtronic Endurant US Ovation study subjects had an aneurysm enlargement rate at 4 years of 10.0% which is comparable to previous EVAR studies that only included US subjects (range 2.1% %). All Ovation study subjects with aneurysm diameter enlargement had a type II endoleak reported by the core lab during one or more follow-up visits. No AAA ruptures or conversions have been reported through 4 years
12 Ovation System Expands EVAR Key Indications Proximal Neck Length Proximal Neck Angle (Degrees) Neck Diameter Iliac Diameter Device Features Profile OD (main body) TriVascular Ovation Cook Zenith Flex Endologix AFX Gore Excluder C3 Lombard Aorfix Medtronic Endurant II No conventional neck length 15mm 15mm 15mm 15mm 10mm requirement 1 <60 if neck length 10 mm 45 if neck length < 10 mm 16-30mm Inner Wall 8-25mm 3 Inner Wall 60 for infrarenal neck 45 degrees for suprarenal neck 18-32mm Outer Wall mm Outer Wall < mm Not Specified 10-23mm Not Specified 19-32mm Inner Wall 8-25mm Inner Wall 19-33mm Inner Wall mm Inner Wall mm Inner Wall 8-25mm Inner Wall 14F-15F 21F-23F 19F 20F 22F 18F-20F *Device Indications from Company Instructions for Use 1 In Ovation pivotal trial, neck length indication of 7mm 2 In healthy landing zones. Measurement is outer wall to outer wall in diseased landing zones. 3 Ovation ix Iliac Stent Graft System
13 Ovation System Improves EVAR Safety & Effectiveness Rates at 1-year TriVascular Ovation IDE Cook Zenith Flex IDE Endologix PowerLink IDE Sources: Ovation data as of June 6, Data Rates from Instructions For Use (IFU) and Annual Clinical Updates 1- Based on Investigator Reported Events 2- Source: Makaroun M. One-year outcomes of the US regulatory trial of the Endurant stent graft system. J Vasc Surg. 2011;54: Includes re-interventions on Day 0. Gore Excluder Combined IDE Lombard Aorfix IDE Medtronic Endurant IDE Patients Enrolled Major Adverse 24.3% / Not Event 2.5% / 3.8% Not Reported 6.3% / 18% 18.6% / 17.1% Reported 0-30 / days All-Cause Mortality 0-30 / days 0.6% / 1.9% 0.5% / 3.0% 1.6% / 5.2% 1.0% / 7.0% 1.8% / Not Reported 4.0% / 6.5% 0% / 4.3% Type I Endoleak 0% 0.6% 0.8% 0.8% 0.7% 0% Type III Endoleak 0% 0.6% 0% 0.9% 0.7% 0% Migration 0% 2.5% 1.6% 0.7% 1.2% 0% AAA Rupture 1 0% 0% 0% 0% 0.5% 0.8% Conversions 1 0% 1% 2.1% 1.1% 1.8% 0% Freedom from 99.3% 98.7% 97.8% 95.0% 98.8% 100% Sac Enlargement Limb Occlusions 1 1.2% 3.0% 3.1% 0.4% 3.7% 2.7% Subjects Requiring Reinterventions 6.2% 11.0% 9.9% 11.5% 15.6% 6.7% 2 1
14 Ovation System Well Suited for Percutaneous Access Access Type In the Ovation pivotal study, subjects undergoing percutaneous access achieved similar clinical outcomes with slightly lower time spent related to anesthesia, procedure and hospitalization time. Cut-Down Percutaneous Percutaneous 43% Cut-down 57% Major Adverse 30 Days 3.3% (3/92) 1.4% (1/69) Treatment 1-year 98.9% (91/92) 100% (69/69) Anesthesia Time (mean) 191 minutes 149 minutes Procedure Time (mean) 118 minutes 98 minutes Hospitalization (median) 2 days 1 day Cut-down Percutaneous
15 Proximal Neck diameter average expansion (mm) Ovation System Protects the Aortic Neck Ovation Global Pivotal study demonstrates encouraging results with stable neck diameter and durable seal through 4 years: Sealing ring technology creates no chronic outward radial force. Aortic Neck Dilatation Over Time* Self-Expanding Stents Open Repair Ovation System 3,4 Baseline 1 Year Growth 2 Year Growth 3 Year Growth 4 Year Growth *Based on all known peer-reviewed published clinical data with clearly outlined methodology to measure neck dilation in patients with self-expanding AAA stent grafts; measurement methodology in cited studies is comparable to measurement methodology in Ovation Pivotal Trial 3,4. 1 Monahan JVS 2010: 52: N=46. Devices: Cook Zenith 2 Rodway Eur J Endovasc Surg 2008; 35: EVAR: N=67, Open: N=56. Data available for up to 2 years. 3 Core Lab evaluation, Ovation Global Pivotal Trial. N=94. Data as of July 31, Neck dilation in proximal neck defined as growth > 3mm at 10mm below renals, 13mm below renals, and 15mm below renals
16 Clinical Evidence to Validate Ovation System Advantages Over 8,000 patients worldwide have been treated with Ovation Abdominal Stent Graft platform, with over 1,000 subjects in a tightly controlled study or registry Patient demographics, anatomical characteristics, and procedural characteristics indicate a challenging patient cohort. At 4 years, no ruptures, conversions, Type I / III endoleaks or migrations were reported, including stable aortic neck diameters. These data provide compelling evidence that the Ovation system can expand EVAR access to more patients and improve EVAR outcomes for all patients
17 INDICATIONS FOR USE: The TriVascular Ovation platform (including Ovation, Ovation Prime and/or Ovation ix Abdominal Stent Graft Systems) is indicated for treatment of patients with abdominal aortic aneurysms having the vascular morphology suitable for endovascular repair, including: adequate iliac/femoral access compatible with vascular access techniques (femoral cutdown or percutaneous), devices, and/or accessories; proximal aortic landing zone: with an inner wall diameter of no less than 16 mm and no greater than 30 mm at 13 mm below the inferior renal artery, and with an aortic angle of 60 degrees if proximal neck is 10 mm and 45 degrees if proximal neck is < 10 mm; distal iliac landing zone: with a length of at least 10 mm, and with an inner wall diameter of no less than 8 mm and no greater than 25 mm (no greater than 20 mm for Ovation/Ovation Prime). CONTRAINDICATIONS: The systems are contraindicated for use in patients who have a condition that threatens to infect the graft and in patients with known sensitivities or allergies to the device materials (including polytetrafluoroethylene [PTFE], polyethylene glycol [PEG]-based polymers, fluorinated ethylene propylene [FEP] or nitinol). Also consider the information in Section 4 Warnings and Precautions of the systems Instructions for Use. Refer to Instructions for Use at TriVascular.com for more information concerning Indications, Contraindications, Warnings and Precautions, and Adverse Events. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. NOTE: Not all product components are available in every country. Please consult with your TriVascular representative to confirm product availability. CE marked. Please refer to current product Instructions for Use.
18 ENGAGE Watch. Interact. Navigate. ATTEND VIVA 16 In September! September 18-22, 2016 Wynn Las Vegas
OVATION: Custom Neck Seal that Benefits you and your Patients, Sustained by Long-term Data
OVATION: Custom Neck Seal that Benefits you and your Patients, Sustained by Long-term Data Disclosures Speaker name: Lieven F. Maene, MD I have the following potential conflicts of interest to report:
More informationRISULTATI A DISTANZA DELL ENDOPROTESI OVATION
RISULTATI A DISTANZA DELL ENDOPROTESI OVATION SONIA RONCHEY MD PhD SAN FILIPPO NERI - ROMA MM1312 Rev 02 2016 Endologix, Inc. Caution: Federal (USA) law restricts this device to sale by or on the order
More information14F OD Ovation Abdominal Stent Graft System
14F OD Ovation Abdominal Stent Graft System 2 Year Results from the European Study Dierk Scheinert, MD Center for Vascular Medicine Angiology and Vascular Surgery Park Hospital Leipzig, Germany Disclosure
More informationAccess More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
More informationTriVascular Ovation Prime Abdominal Stent Graft System
TriVascular Ovation Prime Abdominal Stent Graft System Science of the Seal O-Ring Sealing Technology O-Ring Sealing in Proven Engineering Solutions O-rings are designed to seal by blocking the flow of
More informationENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients
ENCORE, a Study to Investigate the Durability of Polymer EVAR with Ovation A Contemporary Review of 1296 Patients The Ovation System is approved to treat infrarenal abdominal aortic aneurysms and is not
More informationOvation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic
Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
More informationOptimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
More informationNellix Endovascular System: Clinical Outcomes and Device Overview
Nellix Endovascular System: Clinical Outcomes and Device Overview Jeffrey P. Carpenter, MD Professor and Chief, Department of Surgery CAUTION: Investigational device. This product is under clinical investigation
More informationTalent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
More informationDegeneration of the Neck Post Implementation - a New Era of AAA Stent
Degeneration of the Neck Post Implementation - a New Era of AAA Stent New Mexico Heart Institute Albuquerque, New Mexico USA - Gore Current FDA-Approved EVAR Devices Sealing Mechanism Endologix Lombard
More informationINCRAFT system: Update from the Pivotal INSPIRATION Study
INCRAFT system: Update from the Pivotal INSPIRATION Study Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh
More informationDurability of The Endurant Stent-Graft through 5 Years
Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School
More informationAortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
More informationMy personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
More informationImproving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
More informationLOWERING THE PROFILE RAISING THE BAR
LOWERING THE PROFILE RAISING THE BAR INNOVATIVE LOW PROFILE. ADVANCED CLINICAL PERFORMANCE. The AFX TM Endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft
More informationA New EVAR Device for Infrarenal AAAs
A New EVAR Device for Infrarenal AAAs Peter Nelson, MD, MS Assistant Professor of Surgery MM0203 Rev. 01 Current U.S. EVAR Devices Anatomical Fixation Proximal Fixation Powerlink - Endologix Excluder WL
More informationYoung-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University Health System,
Young-Guk Ko, M.D., Dangas G, J Am Coll Cardiol Intv 2012;5:1071 All-cause Mortality Dangas Severance G, J Am Coll Cardiovascular Cardiol Intv Hospital, 2012;5:1071 Yonsei University Health System Aneurysm-related
More informationWhat does the data tell us about outcomes of EVAR in challenging anatomy?
What does the data tell us about outcomes of EVAR in challenging anatomy? UCSF Vascular Surgery Symposium 2018 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery Co-director, Comprehensive Aortic
More informationCAUTION: The Nellix EndoVascular Aneurysm Sealing System is an investigational device. Limited by federal (or United States) law to investigational
Safety and Effectiveness Results of the Nellix System IDE Pivotal Trial for Endovascular Aneurysm Sealing PRESENTED BY: Jeffrey P. Carpenter, MD National Principal Investigator Professor and Chairman,
More informationThe Ventana Off-the-Shelf Graft for Pararenal AAA. Andrew Holden Associate Professor of Radiology Auckland Hospital
The Ventana Off-the-Shelf Graft for Pararenal AAA Andrew Holden Associate Professor of Radiology Auckland Hospital Disclosures Andrew Holden, MBChB, FRANZCR Investigator in Nellix and Ventana Trials Clinical
More informationCurrent Status of Abdominal Aortic Stent Grafts. John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center
Current Status of Abdominal Aortic Stent Grafts John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center Autumn Greetings Disclosure Statement of Financial Interest Within
More informationMid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies Jean-Paul P.M. de Vries Head Department of Surgery, University Medical Centre Groningen The
More informationInfluence of patient selection and IFU compliance on outcomes following EVAS
Influence of patient selection and IFU compliance on outcomes following EVAS LUNCH SYMPOSIUM LINC 2017 Jan MM Heyligers, MD, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg,
More informationCurrent Status of EVAR for Infrarenal AAA. 31 st Annual Florida Vascular Society. PENN Surgery
Current Status of EVAR for Infrarenal AAA 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Stent Grafts Design Related Differences What really matters? Modular Unibody Supported Unsupported
More informationAnalysis of Type IIIb Endoleaks Encountered with Endologix Endografts
Analysis of Type IIIb Endoleaks Encountered with Endologix Endografts Alan R. Wladis, MD, FACS, David Varnagy, MD, FACS, Manuel R. Perez-Izquierdo, MD, Mark Ranson, MD FACS, Delos Clift, MD FACS, Rebecca
More informationConflicts of Interest. When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Summary. Infrarenal EVAR for short necks 2y postop
When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Tim Resch MD Vascular Center Skane University Hospital Conflicts of Interest COOK Medical - Consulting, Speakers Bureau, IP, Research support Medtronic
More informationHostile Proximal Neck: A New Conformable EVAR Device
Hostile Proximal Neck: A New Conformable EVAR Device Young-Guk Ko, M.D., Seoul, Korea Currently Available Devices for EVAR in Korea, 2018 Zenith Flex, Cook Endurant IIs, Medtronic INCRAFT, Cordis AFX2,
More informationGORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
More informationEVAS using Nellix in my practice Where are we today?
EVAS using Nellix in my practice Where are we today? Prof. dr. Michel MPJ Reijnen Department of Vascular Surgery, Rijnstate Hospital Arnhem Faculty of Science and Technology, University of Twente The Netherlands
More informationNASDAQ: ELGX December Innovation that Empowers
NASDAQ: ELGX www.endologix.com December 2014 Innovation that Empowers Safe Harbor This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
More informationThe Auckland Experience with the Nellix EVAS System. Andrew Holden, MBChB, FRANZCR
The Auckland Experience with the Nellix EVAS System Andrew Holden, MBChB, FRANZCR Disclosure Speaker name: Associate Professor Andrew Holden I have the following potential conflicts of interest to report:
More informationChallenging anatomies demand versatility.
Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural
More informationFeasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm
LINC 2019 Leipzig, Germany Feasibility of aortic neck anatomy for endovascular aneurysm repair in Korean patients with abdominal aortic aneurysm Deokbi Hwang, Sujin Park, Hyung-Kee Kim, Seung Huh Division
More informationHistory of the Powerlink System Design and Clinical Results. Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ
History of the Powerlink System Design and Clinical Results Edward B. Diethrich Arizona Heart Hospital Phoenix, AZ Powerlink System: Unibody-Bifurcated Design Long Main Body Low-Porosity Proprietary eptfe
More informationEndoVascular Aneurysm Sealing (EVAS) with Nellix
1 2 EndoVascular Aneurysm Sealing (EVAS) with Nellix Designed to seal entire aneurysm with contained biostable polymer Non-modular design with complete fixation Expands endovascular patient eligibility
More informationTreatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands
Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting
More informationLess Invasive EVAR Transitioning to a Fast-Track Protocol
Less Invasive EVAR Transitioning to a Fast-Track Protocol Mario Lachat, MD University of Zurich Department of Cardiovascular Surgery Switzerland LINC 2015 1 Disclosure Speaker name: Mario Lachat, MD I
More information2014 ANNUAL CLINICAL UPDATE. TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems
2014 ANNUAL CLINICAL UPDATE TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems 2014 ANNUAL CLINICAL UPDATE TriVascular Inc. Ovation and Ovation Prime Abdominal Stent Graft Systems
More informationPredictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg Disclosure
More informationDurable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
More informationZenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up
Zenith Renu AAA Converter Graft Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Device description: Device indications The Zenith Renu AAA Converter Graft with Z-Trak Introduction
More informationWhen to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs JEAN-PAUL P.M. DE VRIES, DIRECTOR OF VASCULAR SURGERY ST.ANTONIUS HOSPITAL NIEUWEGEIN, THE NETHERLANDS. LINC ASIA-PACIFIC HongKong,
More informationConsiderations for a Durable Repair
Considerations for a Durable Repair Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany Disclosures William Cook
More informationEndovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
More informationAbdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
More informationHow to select FEVAR versus EVAR + endoanchors in short-necked AAAs
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs Jean-Paul P.M. de Vries, Richte C.L. Schuurmann St. Antonius Hospital Nieuwegein, The Netherlands 21st Critical Issues Congress Nuernberg,
More informationLow profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment
More informationEVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes?
D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes? Disclosures Speaker name: Dittmar Böckler
More informationChallenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
More informationClinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE)
Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE Iliac Branch Endoprosthesis (IBE) Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon The Netherlands
More informationMid-term results of 300+ patients treated by endovascular aortic sealing (EVAS)
Mid-term results of 300+ patients treated by endovascular aortic sealing (EVAS) Jean-Paul P.M. de Vries Dept Vascular Surgery St. Antonius Hospital, Nieuwegein,The Netherlands On behalf of the DEVASS study
More informationEVAS How does this Impact EVAR Therapy
EVAS How does this Impact EVAR Therapy John S. Lane III, MD, FACS Professor and Acting Chief of Vascular Surgery University of California, San Diego PNEC, 2017 Endologix products and associated components
More informationFROM THE EVERYDAY TO THE EXTRAORDINARY
FROM THE EVERYDAY TO THE EXTRAORDINARY Created with the collaboration of more than 250 physicians around the world, ENDURANT empowers you to create stronger outcomes for more patients, including those
More informationRight Choice for Right Angles
Right Choice for Right Angles The Anatomy of Technology Aorfix gives you technology that conforms to patient anatomy, optimising both procedure and post-operative performance. Fishmouth for optimum neck
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE)
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE GUIDANCE EXECUTIVE (GE) Review of TA167; Endovascular stent-grafts for abdominal aortic aneurysms Final recommendation post consultation The guidance should
More information2015 Clinical Update Endovascular Systems for AAA Repair
Endovascular Systems for AAA Repair 2 Musick Irvine, CA 92618 Tel 949.595.7200 Fax 949.612.1893 www.endologix.com TABLE OF CONTENTS Section Page ABSTRACT... 3 READER S GUIDE... 4 SECTION 1: US PIVOTAL
More informationAorfix Pythagoras US Clinical Trial:
Overall 1 Year Results from the Aorfix Pythagoras US Clinical Trial: 1 st IDE Study in Highly Angulated 60 133 Aortic Necks Mark Fillinger MD for the PYTHAGORAS Investigators Disclosure Speaker name: Mark
More informationEVAS is Associated with Lower All-Cause Mortality
EVAS is Associated with Lower All-Cause Mortality Marc L Schermerhorn, MD Chief, Division of Vascular and Endovascular Surgery Beth Israel Deaconess Medical Center Professor of Surgery Harvard Medical
More informationEvolution of gender-related differences in outcome of EVAR
Evolution of gender-related differences in outcome of EVAR Erik Debing Department of Vascular Surgery University Hospital Brussels Disclosure Speaker name: ERIK DEBING... I have the following potential
More informationHostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
More informationTreating very short necks ( 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights
Treating very short necks ( 4mm
More informationInsights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results Konstantinos P. Donas, Giovanni Torsello Department of Vascular Surgery St. Franziskus Hospital Münster, Germany Disclosure Speaker
More informationIncreased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair
583 Increased Flexibility of AneuRx Stent-Graft Reduces Need for Secondary Intervention Following Endovascular Aneurysm Repair Frank R. Arko, MD; W. Anthony Lee, MD; Bradley B. Hill, MD; Paul Cipriano,
More informationAccessi Iliaci Ostili
Alma Mater Studiorum Bologna University S.Orsola-Malpighi, Bologna, Italy Vascular Surgery Accessi Iliaci Ostili nel trattamento della patologia aortica E. Gallitto Iliac Navigations Alma Mater Studiorum
More informationBilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
More informationTechnology. The introduction of endovascular aortic repair. cover story
Infrarenal EVAR Technology Review Steady evolution in device design and delivery has expanded endovascular repair to more patients, but further advancements are integral to this technology s future. By
More informationAnatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC
Anatomy-Driven Endograft Selection for Abdominal Aortic Aneurysm Repair S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton, FL, USA Disclosures
More informationGORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER Section I Clinical experience. Section II Worldwide commercial experience
GORE EXCLUDER AAA Endoprosthesis ANNUAL CLINICAL UPDATE OCTOBER 2018 Abstract This annual clinical update provides a review of the ongoing experience with the GORE EXCLUDER AAA Endoprosthesis used in the
More informationDisclosures. EVAR follow-up: actual recommendation. EVAR follow-up: critical issues
Disclosures is it time to discuss individualized follow-up schemes based on preoperative anatomy and high quality completion angiography? Consultant / Speaker / Proctor Cook Cordis Medtronic Invatec W.L.
More informationType 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
More informationHow to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium Disclosure Speaker name: Isabelle Van Herzeele I have the following potential
More informationEVAR replaced standard repair in most cases. Why?
EVAR replaced standard repair in most cases. Why? Initial major steps in endograft evolution Papazoglou O. Konstantinos M.D. The story of a major breakthrough in vascular surgery 1991 Parodi introduces
More informationAnatomical challenges in EVAR
Anatomical challenges in EVAR M.H. EL DESSOKI, MD,FRCS PROFESSOR OF VASCULAR SURGERY CAIRO UNIVERSITY Disclosure Speaker name:... I have the following potential conflicts of interest to report: Consulting
More informationNo Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital Disclosures Andrew Holden, MBChB, FRANZCR No financial investment to disclose Investigator
More informationLessons learned from Ch-EVAR for the treatment of. Miltos Matsagkas MD, PhD, FEBVS Professor of Vascular Surgery University of Thessaly
Lessons learned from Ch-EVAR for the treatment of pararenal AAAs Miltos Matsagkas MD, PhD, FEBVS Professor of Vascular Surgery University of Thessaly Ch-EVAR Ch-EVAR = Chimney-EVAR Placement of single
More informationImportant Update to Field Safety Notice Nellix EndoVascular Aneurysm Sealing System Updated Instructions for Use (IFU)
October 6, 2017 Important Update to Field Safety Notice Nellix EndoVascular Aneurysm Sealing System Updated Instructions for Use (IFU) Dear Physician, This notification is to provide you with further information
More informationTHE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY
THE ENDURANT STENT GRAFT IN HOSTILE ANEURYSM NECK ANATOMY Patrice Mwipatayi FCS (SA), MMed, FRACS Professor of Vascular surgery Royal Perth Hospital, University of Western Australia, Perth, WA Co-Authors:
More informationThe evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System
The evolution of AORFIX AORFIX AAA Stent Graft now with the new AORFLEX Delivery System The confident choice for the right angles AORFIX the only AAA stent graft approved for all angulations from 0 90,
More informationEVAS Sealing Technology: The new paradigm in AAA therapy
June 2016 EDUCATIONAL SUPPLEMENT EVAS Sealing Technology: The new paradigm in AAA therapy This educational supplement has been supported by an unrestricted educational grant from Endologix MM1398 Rev 01
More informationFrom 1996 to 1999, a total of 1,193 patients with
THE ANEURX CLINICAL TRIAL AT 8 YEARS Lessons learned following the US AneuRx clinical trial from 1996 to 2004. BY CHRISTOPHER K. ZARINS, MD From 1996 to 1999, a total of 1,193 patients with infrarenal
More informationEndovascular Treatment of the Aorta with Fenestrated and Branched Grafts
Endovascular Treatment of the Aorta with Fenestrated and Branched Grafts Eric LG Verhoeven,MD, PhD, A. Katsargyris, MD Vascular and Endovascular Surgery, Paracelsus Medical University, Nuremberg, Germany
More informationBifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully
Physician Training Bifurcated system Proximal suprarenal stent Modular (aortic main body and two iliac legs) Full thickness woven polyester graft material Fully supported by self-expanding z-stents H&L-B
More informationUse of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies:
Use of Aptus Heli-FX EndoAnchor implants with standard endografts to strengthen seal in hostile anatomies: technical tips, case experience and clinical results CACVS Medtronic Symposium Paris, France January
More informationAAA: DEBATE THERE ARE NO LIMITS USING EVAR FOR AAA. 2 nd -3 rd June 2016.
AAA: DEBATE THERE ARE NO LIMITS USING EVAR FOR AAA JORGE FERNÁNDEZ NOYA ANGIOLOGY AND VASCULAR SURGERY DEPARTMENT UNIVERSITARY CLINICAL HOSPITAL SANTIAGO DE COMPOSTELA 2 nd -3 rd June 2016. 1888 ENDOANEURYSMORRHAPHY
More informationEXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED.
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED. A/Prof. B. Patrice Mwipatayi MD, MMed (Surg), MClinEd (Melb), FCS, FRACS Department of Vascular Surgery, Royal
More informationIs EVAS a proper choice in women?
Is EVAS a proper choice in women? CACVS 2018 Jan MM Heyligers, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg The Netherlands Disclosures Consultant for Endologix DEVASS =Dutch
More informationFEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX
FEVAR FIFTEEN YEARS OF EFFICIENCY E.DUCASSE MD PHD FEBVS CHU DE BORDEAUX 2018 A BIT OF HISTORY First use of F-EVAR : 1990s Park et al. J Vasc Interv Radiol. 1996;7:819-823. Faruqi et al. J Endovasc Surg.
More informationNow that Endoanchors are Approved (and paid for) We have a Durable Solution to Short Necks That s so Easy!
Now that Endoanchors are Approved (and paid for) We have a Durable Solution to Short Necks That s so Easy! David H. Deaton, MD Vascular Surgery / University of South Carolina / Palmetto Health Chief Medical
More informationMODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE
MODERN METHODS FOR TREATING ABDOMINAL ANEURYSMS AND THORACIC AORTIC DISEASE AAA FACTS 200,000 New Cases Each Year Ruptured AAA = 15,000 Deaths per Year in U.S. 13th Leading Cause of Death 80% Chance of
More informationProspective Study of the E-liac Stent Graft System in Patients with Common Iliac Artery Aneurysm: 30-Day Results
Prospective Study of the E-liac Stent Graft System in Patients with Common Iliac Artery Aneurysm: 30-Day Results J. Brunkwall MD, Ph.D, FEBVS On behalf of the Pliant study groups E-liac Stent Graft System
More informationORIGINAL ARTICLE. International Journal of Surgery
International Journal of Surgery (2013) 11(S1), S24 S29 Contents lists available at ScienceDirect International Journal of Surgery journal homepage: www.journal-surgery.net ORIGINAL ARTICLE Treatment of
More informationThe clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study,
The clinical update for the Zenith AAA Endovascular Graft has included results from the Zenith AAA Endovascular Graft multi-center clinical study, the 36 mm diameter Zenith Flex AAA Endovascular Graft
More informationCorporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015
(Nasdaq:EVAR) Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015 Safe Harbor This presentation contains forward-looking statements as that term is defined in the Private Securities Litigation
More informationChungbuk Regional Cardiovascular Center, Division of Cardiology, Departments of Internal Medicine, Chungbuk National University Hospital Sangmin Kim
Endovascular Procedures for Isolated Common Iliac and Internal Iliac Aneurysm Chungbuk Regional Cardiovascular Center, Division of Cardiology, Departments of Internal Medicine, Chungbuk National University
More informationReduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?
February 1, 2018 Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages? Patrick Berg M.D. Marienhospital Kevelaer Germany
More informationWhy Nellix? Treating Concomitant Common Iliac Aneurysms
INDICATIONS FOR USE The Nellix EndoVascular Aneurysm Sealing System can be used in patients who have an infrarenal abdominal aortic (AAA) or aortoiliac aneurysm with suitable anatomy as indicated below:
More informationQuick Reference Guide
Quick Reference Guide Indications for Use The AFX Endovascular AAA System is indicated for endovascular treatment in patients with AAA. The devices are indicated for patients with suitable aneurysm morphology
More information11/20/2014. Disclosures. Kissing Balloons and Stents. Treatment of Aortoiliac Occlusive Disease. Data on Patency of Kissing Stents.
RESULTS FROM A MULTI-CENTER, RETROSPECTIVE REVIEW OF THE AFX ENDOGRAFT FOR USE IN AORTOILIAC OCCLUSIVE DISEASE Disclosures Cook Endologix Medtronic Thomas Maldonado, MD Associate Professor Department of
More information